Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$118.34
Market cap
$2.95B
P/E Ratio
20.51
Dividend/share
$1.55
EPS
$5.77
Enterprise value
$2.69B
Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas,
Highlights
The stock's price to earnings (P/E) is 34% less than its 5-year quarterly average of 30.9 and 2.3% less than its last 4 quarters average of 21.0
The quick ratio is up by 13% YoY and by 4.3% from the previous quarter
The company's EPS rose by 13% YoY but it fell by 4% QoQ
Innospec's net income has increased by 13% YoY but it has decreased by 3.9% from the previous quarter
Innospec's revenue has decreased by 4.7% YoY
IOSP's gross profit is down by 4.2% year-on-year and by 2.3% since the previous quarter
Key stats
What are the main financial stats of IOSP
Market
Valuations
Earnings
Shares outstanding
24.94M
Market cap
$2.95B
Enterprise value
$2.69B
Price to earnings (P/E)
20.51
Price to book (P/B)
2.37
Price to sales (P/S)
1.58
EV/EBIT
14.52
EV/EBITDA
11.8
EV/Sales
1.44
Revenue
$1.87B
EBIT
$185.5M
EBITDA
$228.3M
Free cash flow
$168.9M
Per share
Balance sheet
Liquidity
EPS
$5.77
Free cash flow per share
$6.77
Book value per share
$49.85
Revenue per share
$75.11
TBVPS
$53.8
Total assets
$1.8B
Total liabilities
$550.1M
Debt
$45.7M
Equity
$1.24B
Working capital
$592.5M
Debt to equity
0.04
Current ratio
2.59
Quick ratio
1.69
Net debt/EBITDA
-1.13
Margins
Efficiency
Dividend
EBITDA margin
12.2%
Gross margin
30%
Net margin
7.7%
Operating margin
9.8%
Return on assets
8.3%
Return on equity
12.1%
Return on invested capital
26.1%
Return on capital employed
13%
Return on sales
9.9%
Dividend yield
1.31%
DPS
$1.55
Payout ratio
26.9%
IOSP stock price
How has the Innospec stock price performed over time
Intraday
0.08%
1 week
-2.88%
1 month
6.35%
1 year
11.04%
YTD
-3.98%
QTD
4.64%
Financial performance
How have Innospec's revenue and profit performed over time
Revenue
$1.87B
Gross profit
$562.4M
Operating income
$183.4M
Net income
$143.8M
Gross margin
30%
Net margin
7.7%
The operating margin has increased by 18% year-on-year and by 3.2% since the previous quarter
The net margin rose by 18% year-on-year but it has declined by 2.5% since the previous quarter
Innospec's net income has increased by 13% YoY but it has decreased by 3.9% from the previous quarter
The company's operating income rose by 12% YoY and by 2.5% QoQ
Growth
What is Innospec's growth rate over time
Valuation
What is Innospec stock price valuation
P/E
20.51
P/B
2.37
P/S
1.58
EV/EBIT
14.52
EV/EBITDA
11.8
EV/Sales
1.44
The stock's price to earnings (P/E) is 34% less than its 5-year quarterly average of 30.9 and 2.3% less than its last 4 quarters average of 21.0
The company's EPS rose by 13% YoY but it fell by 4% QoQ
The equity is up by 10% YoY and by 4.3% from the previous quarter
The P/B is 9% less than the last 4 quarters average of 2.6 but 3% more than the 5-year quarterly average of 2.3
The price to sales (P/S) is 5% higher than the 5-year quarterly average of 1.5
Innospec's revenue has decreased by 4.7% YoY
Efficiency
How efficient is Innospec business performance
The company's return on sales rose by 11% YoY
IOSP's ROA is down by 7% since the previous quarter but it is up by 5% year-on-year
IOSP's return on invested capital is up by 7% year-on-year
Innospec's ROE has decreased by 6% from the previous quarter but it has increased by 3.4% YoY
Dividends
What is IOSP's dividend history
DPS
$1.55
Dividend yield
1.31%
Payout ratio
26.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Innospec financials performed over time
The quick ratio is up by 13% YoY and by 4.3% from the previous quarter
The total liabilities has increased by 12% year-on-year and by 9% since the previous quarter
The debt is 96% smaller than the equity
The equity is up by 10% YoY and by 4.3% from the previous quarter
The debt rose by 8% year-on-year but it has declined by 5% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.